News

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the ...
Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...
Kentucky’s independent pharmacies, facing ongoing financial pressure, had hoped for relief from a new law meant to give them ...
Kentucky law to give independent pharmacies financial relief from pharmaceutical industry middlemen has stalled in state ...
We recently published Jim Cramer’s Fresh 14 Stocks & Thoughts About Market Performance. McKesson Corporation (NYSE:MCK) is one of the stocks Jim Cramer recently discussed. McKesson Corporation ...
Independent pharmacies got a win in North Carolina this week after Gov. Josh Stein signed the SCRIPT Act into law.
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.
Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.
New Illinois law aims to bring more oversight and transparency to pharmacy benefit managers, reducing costs and increasing access to prescription drugs, while also providing a starting point for ...